Navigation Links
Cayenne Medical Closes $10 Million Capital Raise

SCOTTSDALE, Ariz., Feb. 14, 2012 /PRNewswire/ -- Cayenne Medical, Inc., a private sports medicine device company, today announced the closing of a $10 million equity financing, with new investor Fletcher Spaght Ventures joining existing investors Split Rock Partners, MB Venture Partners and Investor Growth Capital. The proceeds will be used to enhance the company's sales and distribution and to support expansion of its portfolio of sports medicine orthopedic solutions.

Cayenne Medical currently markets products that address previously unmet clinical needs in knee ligament reconstruction and meniscal repair, including the AperFix® II System, the CrossFix® II System and the iFix® System. This month the company is also launching the Quattro™ Shoulder System for rotator cuff and labral repairs.  

"We are pleased to support Cayenne Medical and its innovative, complete procedural solutions for common sport-related orthopedic injuries," said Peter Kleinhenz of Fletcher Spaght.  "We believe the Company's high quality products, coupled with its impressive executive team will enable even further success as it introduces additional novel soft tissue repair solutions to market."

"Cayenne is privileged to have Fletcher Spaght Ventures join our already strong and committed investor syndicate. We look forward to a year of accelerated company growth, with our new innovative solutions for the shoulder to complement our best-in-class knee products," said David Springer, President and CEO, Cayenne Medical.

About Cayenne Medical, Inc.:Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional soft tissue repair procedures, by applying advanced technology through minimally invasive techniques. For more information, visit

About Fletcher Spaght Ventures:Fletcher Spaght, Inc. was founded in 1983. The firm provides strategy and financing assistance to new ventures, risk capital investors and large enterprises with emerging technologies or other growth opportunities. We develop market research, competitive analysis and financial analysis to advise clients on the commercial potential of new ventures and the options for growing, funding or acquiring new businesses. Fletcher Spaght Ventures invests in high potential companies identified by our practice groups in High Technology, Healthcare and Corporate Growth.  For more information, visit  Randy Buness

Tim Nash Chief Financial Officer

Vice President, Marketing(480) 502-3661

(480) 502-3661  


SOURCE Cayenne Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cayenne Medical, Inc. Launches CrossFix® II Meniscal Repair System
2. Cayenne Medical, Inc. Launches AperFix® II
3. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
4. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
5. Winner Medical Reports First Quarter of Fiscal 2012 Results
6. Sutter Medical Center First in California to Receive Atrial Fibrillation Certification
7. Hitachi Aloka Medical Introduces Diagnostic Ultrasound System F37
8. NorthCrest Medical Center Selects Allscripts Sunrise Electronic Health Record
9. Ronnie Andrews Joins Life Technologies as President, Medical Sciences
10. Canon Europe Acquires Dutch Medical Solutions Specialist Delft DI
11. Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Marker Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
Breaking Medicine Technology:
(Date:11/27/2015)... Raleigh, NC (PRWEB) , ... November 27, 2015 , ... ... most effective ways to treat it. Surviving Mesothelioma has just posted the findings ... Researchers at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
Breaking Medicine News(10 mins):